Drug Information

Drug General Information
Drug ID
D0FH5N
Former ID
DIB014185
Drug Name
IW-6118
Indication Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] Phase 2 [523013]
Company
Ironwood Pharmaceuticals Inc
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Modulator [544183]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 523013ClinicalTrials.gov (NCT01107236) Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction. U.S. National Institutes of Health.
Ref 544183The Discovery and Development of Inhibitors of Fatty Acid Amide Hydrolase (FAAH). Bioorg Med Chem Lett. 2011 August 15; 21(16): 4674-4685.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.